News & Events
Showcasing the latest news stories and event headlines from the world of Neurology

Opticians could keep a closer eye on dementia

2704 1800 Peter Stevenson, PhD

Routine retinal tests performed by opticians could help to identify those at risk of developing dementia, a new study reports. The scans – normally used…

read more

Promoting clean air for brain health

1600 1067 Peter Stevenson, PhD

Every year on the 22nd of July, the World Federation of Neurology (WFN) stages World Brain Day, an awareness-raising initiative involving more than 120 organisations…

read more

World’s first MRI-compatible robot developed for bilateral stereotactic neurosurgery

1600 1018 Peter Stevenson, PhD

Mechanical engineers and surgeons at Hong Kong University (HKU) have designed the first neurosurgical robot capable of performing stereotactic neurosurgery inside an MRI scanner. The…

read more

‘Big Bang’ of Alzheimer’s points to the origin of the disease

1600 1067 Peter Stevenson, PhD

New research has discovered the precise point at which a healthy protein becomes toxic, offering a window into the very beginnings of Alzheimer’s disease (AD).…

read more

Deep brain stimulation effective in early Parkinson’s tremors

1600 1067 Peter Stevenson, PhD

Deep brain stimulation (DBS) could slow the progression of tremors in Parkinson’s disease (PD), according to new data from a pilot trial.1 Researchers at the…

read more

The EAN President’s take on medical education

1024 625 Mea Holm, PhD

At the recent EAN 2018 congress, we met with Professor Franz Fazekas to discuss important advances and ongoing initiatives in medical education and continuous learning…

read more

Headaches and new ways to crush them

1800 1195 Mea Holm, PhD

At the ‘conference highlights’ session of the 2018 EAN meeting, Professor Isabel Pavão Martins presented a summary of the most groundbreaking research in the field…

read more

Rasagiline add-on treatment may offer hope to fast-progressing ALS patients

8001 4501 Mea Holm, PhD

At the ‘late breaking’ session of the EAN 2018 congress, Professor Albert Ludolph from Ulm University (Germany) unveiled the results of a recent double-blind, randomised…

read more

Revolutionary therapies could make spinal muscular atrophy a distant memory

1200 675 Peter Stevenson, PhD

Cutting-edge molecular and genetic therapies for neurogenic disorders took centre stage at the EAN congress, with novel therapies showcased for the treatment of spinal muscular…

read more

From prognosis to prevention: Alzheimer’s biomarkers hold significant promise for the future

1200 675 Peter Stevenson, PhD

Biomarkers could change the landscape of Alzheimer’s disease (AD) forever, but we are only just scratching the surface of their potential, the audience heard during…

read more

The many faces of progressive supranuclear palsy

1200 800 Mea Holm, PhD

Progressive supranuclear palsy (PSP)—a neurodegenerative disease characterized by tau pathology—can have a variety of clinical presentations, delegates heard at an EAN 2018 forum talk delivered…

read more

PML risks linked to MS drug duration

1200 797 Peter Stevenson, PhD

Development of progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS) patients is linked to treatment medications, not the MS itself, delegates heard at the recent…

read more
Brainwork is supported by unrestricted grants from: